Glibenclamide



Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 24.9%
Diabetes Mellitus 21.5%
Product Used For Unknown Indication 15.5%
Drug Use For Unknown Indication 11.2%
Hypertension 8.2%
Arthralgia 2.6%
Osteoporosis 2.6%
Drug Use For Unknown Indication 2.1%
Ischaemic Heart Disease Prophylaxis 1.7%
Prophylaxis Against Gastrointestinal Ulcer 1.7%
Renal Impairment 1.7%
Erectile Dysfunction 1.3%
Cardiac Failure Congestive 0.9%
Hypothyroidism 0.9%
Suicide Attempt 0.9%
Vitamin B12 Deficiency 0.9%
Arthritis 0.4%
Blood Cholesterol Increased 0.4%
Blood Glucose Abnormal 0.4%
Breast Cancer 0.4%
Renal Failure Acute 16.4%
Hypoglycaemia 15.6%
Overdose 12.5%
Suicide Attempt 7.8%
Drug Ineffective 6.3%
Toxicity To Various Agents 5.5%
Myocardial Infarction 4.7%
Completed Suicide 3.1%
Mental Status Changes 3.1%
Sudden Death 3.1%
Death 2.3%
Intentional Overdose 2.3%
Pancreatitis Acute 2.3%
Predisposition To Disease 2.3%
Somnolence 2.3%
Unresponsive To Stimuli 2.3%
Vomiting 2.3%
Weight Decreased 2.3%
Erythema 1.6%
Fracture 1.6%
Secondary
Product Used For Unknown Indication 29.3%
Drug Use For Unknown Indication 20.2%
Type 2 Diabetes Mellitus 11.2%
Diabetes Mellitus 10.5%
Hypertension 8.2%
Helicobacter Infection 4.9%
Osteoporosis 2.8%
Bacteraemia 1.9%
Breast Cancer 1.9%
Duodenal Ulcer 1.5%
Renal Cancer 1.1%
Suicide Attempt 1.0%
Hyperlipidaemia 0.9%
Depression 0.8%
Drug Exposure During Pregnancy 0.8%
Prostate Cancer 0.7%
Renal Cell Carcinoma 0.7%
Prophylaxis 0.6%
Renal Impairment 0.5%
Antiinflammatory Therapy 0.5%
Wheezing 12.2%
Hypoglycaemia 10.9%
Sudden Death 10.9%
Renal Failure Acute 9.0%
Vomiting 7.7%
Completed Suicide 5.8%
Transaminases Increased 5.8%
Myocardial Infarction 5.1%
Toxic Epidermal Necrolysis 5.1%
Death 3.8%
Granulomatous Liver Disease 3.8%
Somnolence 3.2%
Hypoglycaemic Coma 2.6%
Weight Decreased 2.6%
Drug Interaction 1.9%
Glycosylated Haemoglobin Increased 1.9%
Poisoning 1.9%
Renal Failure 1.9%
Toxicity To Various Agents 1.9%
Transient Ischaemic Attack 1.9%
Concomitant
Diabetes Mellitus 20.8%
Drug Use For Unknown Indication 20.7%
Hypertension 18.0%
Product Used For Unknown Indication 7.3%
Type 2 Diabetes Mellitus 6.8%
Rheumatoid Arthritis 5.4%
Dyslipidaemia 3.0%
Hiv Infection 2.7%
Colorectal Cancer 2.0%
Angina Pectoris 1.4%
Prophylaxis 1.3%
Colorectal Cancer Metastatic 1.3%
Constipation 1.3%
Diabetes Mellitus Non-insulin-dependent 1.2%
Nervousness 1.2%
Non-small Cell Lung Cancer 1.2%
Pain 1.1%
Prostate Cancer 1.1%
Thrombosis Prophylaxis 1.1%
Blood Pressure 1.1%
Vomiting 19.1%
Pneumonia 7.7%
Death 7.0%
Renal Failure Acute 6.0%
Myocardial Infarction 5.4%
Weight Decreased 5.0%
Pyrexia 4.7%
Urinary Tract Infection 4.3%
Hypertensive Emergency 4.0%
Dyspnoea 3.7%
Sepsis 3.7%
Syncope 3.7%
Lactic Acidosis 3.3%
Pain In Extremity 3.3%
Paraesthesia 3.3%
Renal Failure 3.3%
Somnolence 3.3%
Gastric Cancer 3.0%
Thrombocytopenia 3.0%
Urticaria 3.0%
Interacting
Drug Use For Unknown Indication 33.0%
Hypertension 10.8%
Type 2 Diabetes Mellitus 8.5%
Diabetes Mellitus 7.1%
Helicobacter Infection 7.1%
Bronchitis 3.8%
Parkinson's Disease 3.8%
Ischaemic Heart Disease Prophylaxis 3.3%
Prophylaxis Against Gastrointestinal Ulcer 3.3%
Renal Impairment 3.3%
Gastric Ulcer 2.4%
Hyperlipidaemia 2.4%
Ill-defined Disorder 2.4%
Device Related Infection 1.9%
Insomnia 1.9%
Dysphagia 1.4%
C-reactive Protein Increased 0.9%
Dysthymic Disorder 0.9%
Gastritis 0.9%
Major Depression 0.9%
Hypoglycaemia 44.4%
Renal Failure Acute 29.6%
Hypomagnesaemia 7.4%
Galactorrhoea 3.7%
Hypoglycaemic Coma 3.7%
Nightmare 3.7%
Portal Vein Thrombosis 3.7%
Rash 3.7%